Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Open access
1,612
Views
11
CrossRef citations to date
0
Altmetric
Research Article
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
David WartherDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA; View further author information
, Ying XiaoDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; ;Provincial Hospital Affiliated to Shandong University, Jinan City, Shandong Province, ChinaView further author information
, Fangting LiDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; View further author information
, Yuqin WangDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; View further author information
, Kristyn HuffmanDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; http://orcid.org/0000-0002-3271-2518View further author information
, William R. FreemanDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; View further author information
, Michael SailorDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA; View further author information
& Lingyun ChengDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; Correspondence[email protected]
View further author information
show allView further author information
Pages 1537-1545
|
Received 06 May 2018, Accepted 05 Jun 2018, Published online: 11 Jul 2018
Related Research Data
Selection of Therapeutic Agents for Intraocular Proliferative Disease
Source:
American Medical Association (AMA)
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Source:
Massachusetts Medical Society
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
Source:
Elsevier BV
Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids
Source:
Elsevier BV
Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial
Source:
Elsevier BV
The Relation Between Bevacizumab Injection and the Formation of Subretinal Fibrosis in Diabetic Patients with Panretinal Photocoagulation
Source:
SLACK, Inc.
Low-Dose Anthracyclines May Block HIF-1 and Stop Tumor Growth
Source:
Oxford University Press (OUP)
Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection.
Source:
American Medical Association (AMA)
Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles
Source:
Elsevier BV
Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).
Source:
Elsevier BV
Multifunctional mesoporous ZrO 2 encapsulated upconversion nanoparticles for mild NIR light activated synergistic cancer therapy
Source:
Elsevier BV
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
Source:
Taylor & Francis
Update on corticosteroids for diabetic macular edema
Source:
Dove Medical Press Ltd.
Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines
Source:
Springer Nature
Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease
Source:
Springer Nature
A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
Source:
Taylor & Francis
Development of Subretinal Fibrosis After Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration
Source:
SLACK, Inc.
Control of experimental massive periretinal proliferation by daunomycin: dose-response relation
Source:
Springer Nature
Dual Drug Release of Triamterene and Aminophylline from Poly (N-Isopropylacrylamide) Hydrogels
Source:
SAGE Publications
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
EXACERBATION OF CHOROIDAL AND RETINAL PIGMENT EPITHELIAL ATROPHY AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Source:
Ovid Technologies (Wolters Kluwer Health)
Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives
Source:
Informa UK Limited
Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon
Source:
Elsevier BV
Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.
Source:
Elsevier BV
Highly Emissive Dye-Sensitized Upconversion Nanostructure for Dual-Photosensitizer Photodynamic Therapy and Bioimaging
Source:
American Chemical Society (ACS)
Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment
Source:
Future Medicine Ltd
Anthracyclines, Small-Molecule Inhibitors of Hypoxia-Inducible Factor-1 Alpha Activation
Source:
Pharmaceutical Society of Japan
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Inflammation and age-related macular degeneration (AMD).
Source:
Informa UK Limited
Recruitment of Blood-Derived Inflammatory Cells Mediated via Tumor Necrosis Factor-α Receptor 1b Exacerbates Choroidal Neovascularization
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Source:
Elsevier BV
Yolk-Structured Upconversion Nanoparticles with Biodegradable Silica Shell for FRET Sensing of Drug Release and Imaging-Guided Chemotherapy
Source:
American Chemical Society (ACS)
Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics
Source:
Informa UK Limited
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
Source:
Taylor & Francis
Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide
Source:
Elsevier BV
INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY
Source:
Ovid Technologies (Wolters Kluwer Health)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit
Source:
Springer Nature
The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment
Source:
Springer Nature
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Characterization of Daunorubicin-Induced Apoptosis in Retinal Pigment Epithelial Cells: Modulation by CD95L
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Porous silicon in drug delivery devices and materials
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.